Patients with a low proportion of INF-γ-producing NK-cells (<45%) show a significantly higher HCC recurrence rate than patients with a high IFN-γ-producing NK-cell proportion (≥45%) one month after treatment133. The gene discussed is IFNG; the disease is hepatocellular carcinoma.